DETERMINANTES CLÍNICOS Y MOLECULARES EN EL TRATAMIENTO PERSONALIZADO CON INMUNOTERAPIA EN CÁNCER DE CÉLULAS RENALES.

Dades bàsiques

Protocol:
SOG-NIV-2019-01
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2022
Any de finalització:
2024
ESTUDIO OBSERVACIONAL

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

ASOC SPANISH ONCOLOGY GENITOURINARY GROUP

Resultats de l'Assaig Clínic


A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)

Gately L; (...); Balana C

Correction. 10.1007/s11060-024-04581-x. 2024

  • Open Access.

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

Gately, L.; (...); Balana, C.

Article. 10.1007/s11060-023-04513-1. 2023


A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA

Gately, Lucy; (...); Balana, Carmen

Meeting Abstract. 2023


Addressing the challenges of cancer care in older adults: The unique benefits of oncogeriatric evaluation and management.

Martinez-Peromingo, Javier; (...); Girones, Regina

Letter. 10.1016/j.regg.2023.03.002. 2023


Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Garrido Siles, Marga; (...); Angel Climent, Miguel

Review. 10.3390/cancers14163968. 2022

  • Open Access.

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.

Garcia-Del-Muro, Xavier; (...); Alemany, Ramon

Article. 10.1158/1078-0432.CCR-24-2636. 2025


Correction: Update on the management of elderly patients with colorectal cancer.

Soler-González G; (...); Gironés-Sarrió R

Correction. 10.1007/s12094-023-03351-x. 2024

  • Open Access.

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

Sarrio, RG; (...); Porta-Sales, J

Article. 10.1186/s12904-020-00693-z. 2021

  • Open Access.

Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer

Feliu, J; (...); Molina-Garrido, MJ

Article. 10.3390/jcm10081615. 2021

  • Open Access.

Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.

Angeles Vaz, Maria; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14046. 2021


Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma

Villar, MV; (...); Santos, JD

Meeting Abstract. 10.1016/j.annonc.2021.08.008. 2021

  • Open Access.

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.

Nadal E; (...); Gironés R

Article. 10.1007/s12094-023-03286-3. 2023

  • Open Access.

Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer.

Torregrosa-Maicas MD; (...); Gironés-Sarrió R

Article. 10.1007/s12094-021-02766-8. 2022

  • Open Access.

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Gately L; (...); Balana C

Article. 10.1007/s11060-024-04668-5. 2024


Final database lock results of the phase 2 cohort of lenvatinib plus pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma

Lee, Chung-Han; (...); Motzer, Robert J.

Meeting Abstract. 2023


Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

Vaz, M. A.; (...); Girones, R.

Meeting Abstract. 10.1016/j.annonc.2023.09.1695. 2023

  • Open Access.

Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study.

Rondan, Maria Arnal; (...); Sarrio, Regina Girones

Article. 10.1007/s12094-024-03657-4. 2024


Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.

Vaz Salgado, Maria Angeles; (...); De Las Penas Bataller, Ramon

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14047. 2021


Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.

Mizutani, Tomonori; (...); Kanesvaran, Ravindran

Article. 10.1016/j.jgo.2024.101709. 2024

  • Open Access.

Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Lee, Chung-Han; (...); Motzer, Robert J

Letter. 10.1016/j.eururo.2024.05.003. 2024


Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

Lee, CH; (...); Motzer, JR

Article. 10.1016/S1470-2045(21)00241-2. 2021

  • Open Access.

P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY

Mazariegos, M.; (...); Pineda, E.

Meeting Abstract. 10.1093/neuonc/noae144.446. 2024

  • Open Access.

Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.

Juan Fita, Maria Jose; (...); Heras, Lucia

Meeting Abstract. 2023


Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.

Juan Fita, Maria Jose; (...); Angel Climent, Miguel

Article. 10.3390/cancers15215223. 2023

  • Open Access.

Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.

Garcia del Muro, Xavier; (...); Vigues, Francesc

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.4505. 2021


Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.

Girones, Regina, Arnal, Maria, Forcano, Silvia

Meeting Abstract. 2023


Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)

Redondo, Andres; (...); Gonzalez-Martin, Antonio

Article. 10.31083/j.ejgo4206163. 2021

  • Open Access.

Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

Vaz, Maria Angeles; (...); Martinez-Garcia, Maria

Meeting Abstract. 2022


SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

Martínez-García M; (...); Manuel Sepúlveda-Sánchez J

Article. 10.1007/s12094-022-02803-0. 2022

  • Open Access.

SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).

Segura, Pedro Perez; (...); Losada, Estela Pineda

Article. 10.1007/s12094-023-03245-y. 2023

  • Open Access.

SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer.

Russo, Chiara; (...); Battisti NML

Article. 10.1016/j.jgo.2023.101564. 2023

  • Open Access.

SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain.

Juan Fita, Maria Jose; (...); Molina Diaz, Aurea

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.e1656. 2024

  • Open Access.

State of the scientific evidence and recommendations for the management of older patients with gastric cancer.

Paredero-Perez, Irene; (...); Girones-Sarrio, Regina

Article. 10.1016/j.jgo.2023.101657. 2023

  • Open Access.

Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective.

Del Barco, Sonia; (...); Servitja, Sonia

Article. 10.1007/s12094-024-03838-1. 2025


The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer.

Mislang AR; (...); Battisti NML

Letter. 10.1016/j.jgo.2021.03.003. 2021

  • Open Access.

Undertreatment and overtreatment in older patients treated with chemotherapy.

Feliu J; (...); Molina-Garrido MJ

Article. 10.1016/j.jgo.2020.10.010. 2020


Update on the management of elderly patients with colorectal cancer.

Soler-Gonzalez, Gemma; (...); Girones-Sarrio, Regina

Article. 10.1007/s12094-023-03243-0. 2023

  • Open Access.

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.

Guillot Morales M; (...); Gironés Sarrió R

Article. 10.1007/s12094-024-03386-8. 2024

  • Open Access.

Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.

Soto-Perez-de-Celis, Enrique; (...); Battisti, Nicolo Matteo Luca

Article. 10.1016/j.jgo.2022.07.005. 2022

  • Open Access.

Compartir el projecte